Geneos Wealth Management’s Leidos LDOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.41M | Sell |
9,088
-1,338
| -13% | -$240K | 0.03% | 424 |
|
|
2025
Q4 | $1.88M | Sell |
10,426
-956
| -8% | -$181K | 0.05% | 363 |
|
|
2025
Q3 | $2.15M | Buy |
11,382
+415
| +4% | +$72.2K | 0.05% | 331 |
|
|
2025
Q2 | $1.73M | Sell |
10,967
-9,764
| -47% | -$1.44M | 0.04% | 400 |
|
|
2025
Q1 | $2.8M | Buy |
20,731
+12,628
| +156% | +$1.76M | 0.04% | 412 |
|
|
2024
Q4 | $1.17M | Sell |
8,103
-112
| -1% | -$18.6K | 0.04% | 380 |
|
|
2024
Q3 | $1.34M | Sell |
8,215
-1,102
| -12% | -$167K | 0.05% | 344 |
|
|
2024
Q2 | $1.36M | Buy |
9,317
+129
| +1% | +$18K | 0.06% | 312 |
|
|
2024
Q1 | $1.2M | Buy |
9,188
+1,249
| +16% | +$149K | 0.06% | 322 |
|
|
2023
Q4 | $859K | Buy |
7,939
+278
| +4% | +$28.3K | 0.04% | 354 |
|
|
2023
Q3 | $706K | Sell |
7,661
-176
| -2% | -$16.6K | 0.04% | 389 |
|
|
2023
Q2 | $693K | Sell |
7,837
-398
| -5% | -$33.9K | 0.04% | 391 |
|
|
2023
Q1 | $758K | Sell |
8,235
-383
| -4% | -$37K | 0.05% | 355 |
|
|
2022
Q4 | $907K | Sell |
8,618
-1,071
| -11% | -$110K | 0.05% | 291 |
|
|
2022
Q3 | $847K | Sell |
9,689
-1,346
| -12% | -$131K | 0.06% | 282 |
|
|
2022
Q2 | $1.13M | Buy |
11,035
+6,047
| +121% | +$627K | 0.06% | 294 |
|
|
2022
Q1 | $538K | Hold |
4,988
| – | – | 0.02% | 514 |
|
|
2021
Q4 | $443K | Buy |
4,988
+4,575
| +1,108% | +$428K | 0.02% | 619 |
|
|
2021
Q3 | $40K | Hold |
413
| – | – | ﹤0.01% | 1597 |
|
|
2021
Q2 | $42K | Sell |
413
-400
| -49% | -$41.1K | ﹤0.01% | 1563 |
|
|
2021
Q1 | $82K | Hold |
813
| – | – | ﹤0.01% | 1387 |
|
|
2020
Q4 | $39K | Buy |
813
+400
| +97% | +$38.4K | ﹤0.01% | 1572 |
|
|
2020
Q3 | $38K | Hold |
413
| – | – | ﹤0.01% | 1366 |
|
|
2020
Q2 | $37K | Hold |
413
| – | – | ﹤0.01% | 1355 |
|
|
2020
Q1 | $38K | Hold |
413
| – | – | ﹤0.01% | 1229 |
|
|
2019
Q4 | $40K | Hold |
413
| – | – | ﹤0.01% | 1367 |
|
|
2019
Q3 | $35K | Hold |
413
| – | – | ﹤0.01% | 1349 |
|
|
2019
Q2 | $32K | Sell |
413
-39
| -9% | -$2.85K | ﹤0.01% | 1407 |
|
|
2019
Q1 | $28K | Buy |
452
+14
| +3% | +$845 | ﹤0.01% | 1412 |
|
|
2018
Q4 | $22K | Hold |
438
| – | – | ﹤0.01% | 1461 |
|
|
2018
Q3 | $30K | Sell |
438
-204
| -32% | -$13.8K | ﹤0.01% | 1405 |
|
|
2018
Q2 | $37K | Hold |
642
| – | – | ﹤0.01% | 1188 |
|
|
2018
Q1 | $42K | Buy |
642
+25
| +4% | +$1.65K | ﹤0.01% | 1065 |
|
|
2017
Q4 | $39K | Buy |
617
+154
| +33% | +$9.65K | ﹤0.01% | 1114 |
|
|
2017
Q3 | $27K | Buy |
463
+52
| +13% | +$2.9K | ﹤0.01% | 1208 |
|
|
2017
Q2 | $21K | Buy |
411
+2
| +0.5% | +$106 | ﹤0.01% | 1255 |
|
|
2017
Q1 | $20K | Sell |
409
-489
| -54% | -$25.2K | ﹤0.01% | 1238 |
|
|
2016
Q4 | $45K | Sell |
898
-408
| -31% | -$19.1K | 0.01% | 875 |
|
|
2016
Q3 | $56K | Buy |
1,306
+1,231
| +1,641% | +$55.9K | 0.01% | 772 |
|
|
2016
Q2 | $3K | Hold |
75
| – | – | ﹤0.01% | 1621 |
|
|
2016
Q1 | $3K | Buy |
+75
| New | +$3.58K | ﹤0.01% | 1610 |
|
Other funds holding LDOS
DAM
VCM
VPM
Geneos Wealth Management's LDOS Position: Q1 2026 in Review
Geneos Wealth Management reduced its Leidos (LDOS) stake by 13% in Q1 2026, selling an estimated $240K and leaving 9,088 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #424.
Geneos Wealth Management first reported a position in LDOS in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.8M in Q1 2025. 897 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.
- Geneos Wealth Management held 9,088 shares of Leidos worth $1.41M as of Q1 2026.
- Geneos Wealth Management sold 1,338 Leidos shares in Q1 2026, an estimated $240K.
- Leidos made up 0.03% of Geneos Wealth Management's portfolio in Q1 2026, its #424 holding.
- Geneos Wealth Management first reported a position in Leidos in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Leidos position peaked at $2.8M in Q1 2025.
- 897 funds tracked by Wall St. Rank held Leidos as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.